Inhouse ConsultantDr. Bhavesh Poladia
Dr. Bhavesh Poladia DNB, DM
Qualification: D.N.B., D. M. Medical Oncology
Designation: Senior Consultant
Department: Medical Oncology
About the Doctor
Name: Dr. Bhavesh Pradeep Poladia
TNMC Reg No: 120251
Email: bhaveshpoladia@gmail.com
Contact: 9819151554
Address: Thangam Hospital, 54 Dr. Sankaran road, Namakkal-637001, Tamil Nadu.
Present status: Working as a Medical Oncology Consultant at Thangam Cancer Centre, Namakkal, Tamilnadu.
Experience
Jan 2004 to Dec 2004 – Grant Medical College & Sir J.J. Group of Hospitals, Mumbai.
August 2006 to July 2010 – General Medicine department in Lilavati Hospital and Research Centre, Mumbai.
August 2010 To July 2016 – Medical Oncology department in Tata Memorial Hospital (TMH), Mumbai.
September 2016 till date – Thangam Hospital and Thangam Cancer Centre, Namakkal, Tamilnadu.
Research
As a contributing author in ‘Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer – An Indian exploratory analysis study’ South Asian Journal of Cancer, January 2019.
As a contributing author in ‘Docetaxel/Oxaliplatin/Capecitabine (TEX) triplet followed by continuation monotherapy in advanced gastric cancer’ Indian Journal of Cancer, January 2018.
As a contributing author in ‘Outcome of metastatic neuroendocrine tumors with Cap-Tem regimen: A retrospective tertiary care center analysis’ Digestive Surgery, January 2016.
As a contributing author in ‘Retrospective Analysis of Prospective Database Assessing the Efficacy and Tolerability of First Line Docetaxel Based Chemotherapy Followed by Docetaxel or Capecitabine Maintenance in Non-progressive, Metastatic stomach adenocarcinoma-Experience from tertiary referral centre’ Digestive Surgery, January 2016.
As a first author in ‘Development of hyponatremia on neoadjuvant chemotherapy in locally advanced head & neck cancers’ Conference Paper in ESMO, January 2013.
As a contributing author in ‘Epidemiology of oral cancers referred for NACT, the demographics, clinical profile, and organ functions’ Conference Paper in ASCO, January 2013.
As a contributing author in ‘Induction Chemotherapy in Locally Advanced Pharyngolaryngeal Cancers with Stridor: Is It Feasible and Safe?’ Chemotherapy Research and Practice, August 2012.
As a contributing author in ‘Unusual coexistence of renal anomaly and germ cell tumour: An embryonal happenstance?’ Indian Journal of Medical and Paediatric Oncology, July 2012.
As a second author in ‘Hyperammonemic Coma Presenting as Hashimoto’s Encephalopathy’ Journal of the Association of Physicians of India, October 2008.
Academic
2015 – Homi Bhabha National Institute, DM Medical Oncology, Tata Memorial Hospital (TMH), Mumbai.
2010 – National Board of Examination – DNB General Medicine, Lilavati Hospital and Research Centre, Mumbai.
2003 – Grant Medical College & Sir J.J.Group of Hospitals, Mumbai.
